SUMMARY Amongst 300 patients with Crohn's disease followed between 1944 and 1968, corticosteroids or corticotrophin was given to 124 patients, to 87 of them for more than 12 months. In the short-term assessment of 89 of these patients, 76% improved clinically within six months, but within 12 months 29 % of these had relapsed. In the long term, the risk of operation each year for the patients treated with steroids was twice that of those not treated. There was a significantly increased mortality rate in the patients treated with steroids which in part was due to complications induced by this therapy for which no evidence of long-term benefit emerged from this study.
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Initial reports suggested that therapy with corticotrophin (ACTH) might be beneficial in the treatment of Crohn's disease. Standley, Rosenberg, and Cleroux (1951) claimed excellent immediate responses in seven of the eight patients treated, discontinuing therapy after three or four weeks. Two of the patients remained symptomatically well over the following 12 months. They concluded that 'in cases resistant to the usual methods of treatment, maintenance therapy with corticotrophin or cortisone seems indicated to control symptoms'. Kirsner, Palmer, and Klotz (1952) treated four patients with severe chronic regional enteritis. They noted clinical improvement in three patients and considered 'the beneficial effect less pronounced than in ulcerative colitis'. Gray, Reifenstein, Benson, and Young (1951) were impressed by the dramatic effects in two patients and concluded that there was a good rationale for long-term maintenance therapy. A cautionary note was introduced by Sauer, Brown, and Dearing (1952) as the result of their study with ACIH in 12 patients. They wrote: 'the subjective improvement of these patients was not consistent enough to warrant any enthusiasm especially in view of the tendency towards 922 W. T. Cooke and.J. F. Fielding should be considered as 'palliative conservative measures in preparation for the most desirable time for surgical intervention'. In this paper, we attempt to assess the short-and long-term effects of ACTH or corticosteroids and its place in therapy in regional enteritis.
Cliniical Material and Methods
In general, steroid' therapy was administered: (1) for diffuse jejuno-ileitis in the absence of obstructive symptoms; (2) following re-operation for early recurrence, eg, 12-18 months after the initial operation; (3) for persistent disease activity (as indicated by low serum albumin levels, high serum seromucoids; Cooke, Fowler, Cox, Gaddie, and Meynell, 1958) and failure to attain clinical remission but with no indication for surgical resection; (4) to control diarrhoea, malaise, and disease activity in Crohn's colitis.
The type of therapy given is shown in two years, and 65 (52 %) for more than two years. Therapy was continuous in 77 % and intermittent in 23% of the patients. Forty-seven (38%) had continuous therapy for a mean period of 5.5 years (range 2-14.7 yr). Just over half of the 124 patients received their treatment within one year of diagnosis.
In 89 patients, treatment had been initiated under our own supervision and these patients formed the group on whom the short-term effects of therapy were assessed. Of these 89, 71 patients had steroid therapy for more than 12 months, 13 were treated between six and 12 months, and five had treatment for less than six months. In the remaining patients, treatment had been initiated elsewhere before referral.
Response to steroid therapy was assessed in the short term by the clinical, haematological, and biochemical changes produced and in the long term by the operation and mortality rates.
The optimum clinical response within six months following initiation of therapy was considered 'good' if the patient became symptom free, 'fair' if the patient gained at least 7 lb in weight and had some symptomatic improvement (eg, decreased (Table IV) .
LONG-TERM RESULTS

Response
Good Fair None difference in the relapse rate at 12 months between Operation rates in the small intestine those with large bowel and those with small All operations involving excisional or by-pass intestinal disease. A relatively greater proportion surgery were recorded from the time of diagnosis of patients receiving ACTH improved than those to 18 years later, together with the number of on oral corticosteroids alone. They also did better patients at risk in each year. Hence, the probthan those patients started on ACTH and main-ability of any one patient having such an operation tained on oral corticosteroids (Table IV and fourth 5 and 6 0, and for the fifth and sixth years 10 and 5 % respectively. Operation rates in the large intestine Operation rates were similarly determined from time of diagnosis to eight years later in 51 patients with large bowel disease and the rates of the 33 such patients who received corticosteroid therapy compared with those of the 18 patients who did not. The operative rate for these 51 patients with large bowel disease are shown in Fig. 2 , and it will be seen that steroid therapy did not lessen the likelihood either of excision of the colon or of affecting the years since diagnosis at which it would be performed.
Mortality rates Mortality rates were determined by reference to the Registrar General's life expectancy tables for 1951. Each patient was matched for age, sex, and years at risk from the onset of symptoms with a representative of the general population, and the expected mortality for the group determined for comparison with that which actually occurred (Prior, Fielding, Waterhouse, and Cooke, 1970 ). As it is not possible to assess mortality risk for those patients followed for less than one year the mortality rates were calculated in 295 patients only.
There was a significant increase in the number of deaths in patients with regional enteritis who were less than 40 years old at onset compared with the expected frequency (Table V) . There was also a significantly greater number of deaths in the steroid-treated group compared with the un- Such examples make us reluctant to accept without reservation the ready explanation for the increased mortality amongst the steroid-treated patients.
In Table VI therapy. Even in those patients in whom death was attributable to the use of steroids, the quality of life was often immeasurably improved. Thus, case 30, aged 20, was enabled to work as a carpenter and provide a home for a wife and family until stricken with malignant hypertension. Without such domestic and economic pressure conservative therapy might have allowed the disease to burn out leaving a healthy patient able to lead a normal working life. Case 77 was first seen with an abdominal mass after intestinal resection 12 months previously. Radiological examination demonstrated considerable ileal involvement in the pre-anastomotic area. At the request of the surgeon, steroid therapy was started, resulting in great clinical improvement, return to apparent radiological normality, and normal laboratory findings. After six years' apparent good health the therapy was stopped. Within 12 months recurrence had occurred necessitating two operations, including the establishment of an ileostomy (Fig. 3) . This pattern of containment and even regression of the disorder has been noted many times. Normal economic life has been made possible but recurrence following cessation of therapy was seen on many occasions.
It is, however, difficult to avoid the conclusion that steroid therapy was partly responsible for the significantly increased mortality rate amongst men, particularly when the onset of symptoms was before the age of 40. On the other hand, the only significant increase in mortality rate amongst women was in those under 40 and not treated with steroids; six of the eight deaths which occurred in this group were directly related to the disease. It is possible, therefore, to attribute the significantly lower mortality rate in the treated women with onset under 40 to steroids. In the men and women in whom the onset was after the age of 40, there was no significant increase in the mortality rate and it would be difficult therefore to demonstrate the efficacy of steroid therapy in this group. 63' 6.c65 66 67'68 69,1970 Fig . 3 The return to normality of serum albumin (N > 3.8 g/100 ml) and serum seromucoids (N < 150 mg/100 ml) and weight gain with ACTH. There is a gradual regression with diminishing dosage and eventual relapse leading to further resection (lefthand arrow) and ileostomy and colectomy (right-hand arrow). The patient has remained well and working between 1967 and 1970.
Our own experience leads us to recognize that serious complications may follow steroid therapy leading to the death of the patient. Even so recognition that serious complications occur did not prevent their occurrence. However, the ability of steroid therapy to promote restoration of clinical well being and normal laboratory findings ensures a place in therapy. In our view, steroid therapy had a beneficial effect in controlling symptoms and signs in a patient in whom treatment would otherwise entail a prolonged period of conservative therapy and restricted activities. How such therapy leads to an increase in both the number and chance of operations remains to be answered. In both groups, steroid treated and those not treated, the indications for surgical therapy were the same: enteroenteric and other fistula, recurrent intestinal obstruction, and diagno3tic laparotomy to ascertain the exact extent of the disease. Resection in both groups has been limited to excision of the smallest length of intestine necessary to remove the obstruction, fistula, and other complications. Steroid therapy may well suppress the exudative aspect of the disorder and allow the reparative fibrosing processes of the individual time to act.
In conclusion, some unexpected findings have emerged from this study: the increased mortality and the increased probability of operation for by-pass or resection in steroid-treated patients. Whilst there was no significant difference between men and women with regard to operation rate, the mortality rate for 153 women was significantly less than the mortality rate for 142 men. Much of this difference was attributable to the 11 deaths due to steroid therapy in men in contrast to one only due to this cause in women. Whether this indicates that Crohn's disease is a milder disorder in women than in men will need a larger series of observations to determine. In our hands treatment with steroids carried significant risk, and evidence of long-term benefit in this disorder has not been forthcoming.
